Urinary neopterin in patients with advanced colorectal carcinoma

International Journal of Biological Markers

Volumn 21, Issue 3, 2006, Pages 190-198

  Melichar, Bohuslav ^a   Solichova D ^a   Melicharova K ^a   Malirova E ^a   Cermanova M ^a   Zadak Z ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Colorectal carcinoma; Metastasis; Neopterin

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CREATININE; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; IRINOTECAN; MELPHALAN; NEOPTERIN; OXALIPLATIN; RALTITREXED; TEGAFUR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; ENTERITIS; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEUKOCYTE COUNT; LIVER METASTASIS; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS;

EID: 33750506109     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.782     Document Type: Article

References (29)

1. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22: 229-37.
2. Melichar B, Voboril Z, Cerman J, et al. Survival of patients with colorectal cancer liver metastases treated by regional chemotherapy. Hepatogastroenterology 2006; 53: 422-30.
3. Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil - leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004; 22: 1209-14.
4. Hurwitz H, Febrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-42.
5. Cunningham D, Hurnblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004; 351: 337-45.
6. Weiss G, Kronberger P, Conrad F, Bodner E, Wachter H, Reibnegger G. Neopterin and prognosis in patients with adenocarcinoma of the colon. Cancer Res 1993; 53: 260-5.
7. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989; 27: 81-141.
8. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today 1988; 9: 150-5.
9. Reibnegger G, Fuchs D, Fuith LC, et al. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. Cancer Detect Prev 1991; 15: 483-90.
10. Melichar B, Jandik P, Solichova D, et al. Urinary neopterin excretion in colorectal cancer. Onkologie 1994; 17: 434-6.
11. Allen-Mersh TG, Glover C, Fordy C, Henderson DC, Davies M. Relation between depression and circulating immune products in patients with advanced colorectal cancer. J Roy Soc Med 1998; 9: 408-13.
12. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355: 1041-7.
13. Melichar B, Kohlova T, Vesely P. Survival after oxaliplatin therapy of irinotecan-pretreated advanced colorectal cancer patients. Hepatogastroenterology 2005; 52: 1707-14.
14. Melichar B, Dvorak J, Jandik P, et al. Regional administration of irinotecan in combination with 5-fluorouracil and leucovorin in patients with colorectal cancer liver metastases - a pilot experience. Hepatogastroenterology 2001; 48: 1721-6.
15. Cermanova M, Melichar B, Solichova D, et al. Urinary neopterin and microalbuminuria in patients treated by low-density lipoprotein apheresis. Pteridines 2005; 16: 174-83.
16. Solichova D, Melichar B, Blaha V, et al. Biochemical profile and survival in nonagenarians. Clin Biochem 2001; 34: 563-9.
17. Melichar B, Solichova D, Svobodova I, Urbanek L, Melicharova K. Urinary neopterin in patients with upper gastrointestinal, biliary and pancreatic carcinomas. Pteridines 2006; 17: 20-4.
18. Hanke B, Riedel C, Lampert S, et al. CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA). Ann Oncol 2001; 12: 221-6.
19. Niederwieser D, Fuchs D, Hausen A, et al. Neopterin as a new biochemical marker in the clinical assessment of ulcerative colitis. Immunobiology 1985; 170: 320-6.
20. Reibnegger G, Bollbach R, Fuchs D, et al. A simple index relating clinical activity of Crohn's disease with T cell activation: Hematocrit, frequency of liquid stools and urinary neopterin as parameters. Immunobiology 1986; 173: 1-11.
21. Huang A, Fuchs D, Widner B, Glover C, Henderson DC, Allen-Mersh TG. Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Br J Cancer 2002; 86: 1691-6.
22. Vesely P, Touskova M, Melichar B. Phenotype of peripheral blood leukocytes and survival of patients with metastatic colorectal cancer. Int J Biol Markers 2005; 20: 126-33.
23. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160: 310-6.
24. Werner ER, Werner-Felmayer G, Fuchs D, et al. Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. GTP-cyclohydrolase I is stimulated by interferon-gamma, and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present. J Biol Chem 1990; 265: 3189-92.
25. Fuchs D, Milstien S, Kramer A, et al. Urinary neopterin concentrations vs total neopterin for clinical utility. Clin Chem 1989; 35: 2305-7.
26. Fuchs D, Hausen A, Reibnegger G, et al. Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol 1991; 46: 65-70.
27. Denz H, Fuchs D, Huber H, et al. Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Eur J Haematol 1990; 44: 186-9.
28. Wachter H, Artner-Dworzak E, Fuchs D, et al. Association between neopterin and iron metabolism in cancer patients. Tumor Diagn Ther 1990; 11: 229-32.
29. Kaser A, Brandacher H, Steuer W, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001; 98: 2720-5.